1477.HK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:08):

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China...

Stats
今日成交量	834 000
平均成交量	646 706
市值	4.82B
EPS	HKD0 ( 2023-08-24 )
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-11.17
ATR14	HKD0.0260 (0.36%)

音量相关性

長: -0.12 (neutral)

短: 0.38 (neutral)

Signal:(45.765) Neutral

Ocumension Therapeutics 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Ocumension Therapeutics 相关性 - 货币/商品

-0.76
( moderate negative )

-0.68
( moderate negative )

0.00
( neutral )

-0.74
( moderate negative )

0.25
( neutral )

0.56
( weak )

Ocumension Therapeutics 财务报表

Annual	2023
营收:	HKD246.37M
毛利润:	HKD144.37M (58.60 %)
EPS:	HKD-0.590

FY	2023
营收:	HKD246.37M
毛利润:	HKD144.37M (58.60 %)
EPS:	HKD-0.590

FY	2022
营收:	HKD158.96M
毛利润:	HKD102.92M (64.74 %)
EPS:	HKD-0.640

FY	2021
营收:	HKD56.15M
毛利润:	HKD36.94M (65.78 %)
EPS:	HKD-0.452

Financial Reports:

No articles found.

Ocumension Therapeutics

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. As of December 31, 2021, the company had 20 drug assets in its portfolio. Ocumension Therapeutics was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.